IDEAYA Biosciences, Inc.
IDYA
$40.17
$0.220.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.12% | -18.33% | -169.83% | 253.88% | -7.36% |
| Total Depreciation and Amortization | -1.92% | -4.51% | 16.21% | -16.46% | 8.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.37% | 29.76% | 0.33% | 11.54% | 42.07% |
| Change in Net Operating Assets | -15.96% | 147.63% | -259.67% | 154.01% | 8.58% |
| Cash from Operations | -17.35% | 16.94% | -163.63% | 327.64% | -3.53% |
| Capital Expenditure | 10.44% | -190.39% | -692.86% | 93.67% | 50.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -229.31% | 223.38% | -332.47% | -10.24% | -42.60% |
| Cash from Investing | -231.09% | 221.97% | -333.50% | -9.04% | -42.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18,236.22% | -44.13% | 607.64% | -75.02% | -95.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,566,866.67% | -- | -- | -- | -- |
| Cash from Financing | 30,315.75% | -44.55% | 607.64% | -75.02% | -95.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 155.91% | 124.19% | -200.87% | 1,300.46% | -133.65% |